Skip to main content

Your search for “Immunotherapy” returned 115 results

DNA Mutations Shed in Blood Predicts Response to Immunotherapy in Patients with Cancer

October 1, 2017

In a first-of-its-kind study, University of California San Diego School of Medicine researchers report that a blood sample, or liquid biopsy, can reveal which patients will respond to checkpoint inhibitor-based immunotherapies.

Nanoengineers Receive $4.3M From NIH To Continue Studies Using Plant Viruses To Treat Cancer

October 17, 2022

Researchers led by Nicole Steinmetz, professor of nanoengineering at the University of California San Diego, have received $4.3 million in grants from the National Institutes of Health (NIH) to advance their research using plant viruses to develop cancer immunotherapies.

Boosting Immune Cell Memory to Improve Vaccines and Cancer Immunotherapy

August 28, 2017

…could be used to improve how well vaccines and immunotherapies work and how long they last.

Drug Combination May Improve Impact of Immunotherapy in Head and Neck Cancer

September 21, 2017

Checkpoint inhibitor-based immunotherapy has been shown to be very effective in recurrent and metastatic head and neck cancer but only in a minority of patients. University of California San Diego School of Medicine researchers may have found a way to double down on immunotherapy’s effectiveness.

Poison Drummer Rikki Rockett Cancer-Free Following Immunotherapy at UC San Diego Health

July 18, 2016

…UC San Diego Health, where he underwent experimental cancer immunotherapy, which has now eradicated the tumor.

UC San Diego Health Begins Treating Multiple Myeloma with CAR T-cell Therapy

June 3, 2021

As the first designated medical center in San Diego certified to offer this type of immunotherapy, UC San Diego Health will begin treating patients this month.

Rock Tour “Text2Give” Supports Immunotherapy at UC San Diego Health

April 19, 2017

…would survive tongue cancer but after participating in an immunotherapy clinical trial at Moores Cancer Center at UC San Diego Health, he was declared cancer-free in July 2016. To give back, Rockett is now asking concert-goers to join him in supporting immunotherapy at Moores Cancer Center.

UC San Diego Health Treats 1st Cancer Patient with Stem-Cell Derived Natural Killer Cells

April 1, 2019

Moores Cancer Center at UC San Diego Health treats the first patient treated for cancer with a human-induced pluripotent stem cell (iPSC)-derived cell therapy called FT500. Dan Kaufman collaborated with Fate Therapeutics to bring the iPSC-derived natural killer cell cancer immunotherapy to patients.

Cancer Immunotherapy Might Benefit From Previously Overlooked Immune Players

September 20, 2018

…September 20 in Cell, may help researchers improve cancer immunotherapies and predict which patients will respond best.

CAR-T Immunotherapies May Have a New Player

June 29, 2018

Emerging CAR-T immunotherapies leverage modified versions of patient’s T-cells to target and kill cancer cells. In a new study, researchers at University of California San Diego School of Medicine and University of Minnesota report that similarly modified natural killer (NK) cells derived from human induced pluripotent stem cells (iPSCs) also…

Category navigation with Social links